Literature DB >> 17954023

High frequency of level II-V lymph node involvement in RET/PTC positive papillary thyroid carcinoma.

Y L Wang1, R M Zhang, Z W Luo, Y Wu, X Du, Z Y Wang, Y X Zhu, D S Li, Q H Ji.   

Abstract

AIMS: To investigate the frequency and clinical significance of RET rearrangement in Chinese patients with papillary thyroid carcinoma (PTC) and discuss the role of RET rearrangement in therapeutic decision-making after the performance of level VI lymph node dissection and the 2002 AJCC staging system.
METHODS: RET/PTC-1 and RET/PTC-3 were detected in 126 PTCs using reverse transcription-polymerase chain reaction (RT-PCR) and direct sequencing.
RESULTS: RET rearrangement was detected in 18 cases of PTC. The patient group aged < 20 years had the highest frequency (3/6) of RET rearrangement among the age groups (< 20 years, 20-40 years and > or = 40 years; P=0.03). RET/PTC-1 positive patients were more likely to suffer from Hashimoto's thyroiditis simultaneously (P=0.02) while RET/PTC-3 positive patients had a higher frequency of extrathyroidal extension (P<0.01) and advanced T classification (P<0.01). RET rearrangement (OR=8.70, 95% CI 1.69-44.81), male (OR=3.88, 95% CI 1.41-10.69), age (OR=0.96, 95% CI 0.93-0.99), multifocality (OR=3.54, 95% CI 1.33-9.41) and advanced T classification (OR=7.32, 95% CI 2.91-18.40) were all identified as risk factors of level II-V lymph node involvement in the multivariate analysis.
CONCLUSIONS: The frequency of RET rearrangement in Chinese patients is low and age related. RET/PTC-1 and RET/PTC-3 are associated with different clinical pathological characteristics but not with lymph node involvement. The RET/PTC positive patients should receive more attention to lateral neck in the management of PTC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17954023     DOI: 10.1016/j.ejso.2007.08.012

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  7 in total

1.  Classification of locoregional lymph nodes in medullary and papillary thyroid cancer.

Authors:  T J Musholt
Journal:  Langenbecks Arch Surg       Date:  2013-12-05       Impact factor: 3.445

2.  Association between rs12045440 Polymorphism in the CAPZB Intron and Serum TSH Concentrations in Chinese Thyroid Tumor Patients.

Authors:  Shouhao Feng; Shengli Lin; Jidong Zou; Yulong Wang; Qinghai Ji; Zhenghua Lv
Journal:  Int J Endocrinol       Date:  2015-07-26       Impact factor: 3.257

3.  Radiation exposure, young age, and female gender are associated with high prevalence of RET/PTC1 and RET/PTC3 in papillary thyroid cancer: a meta-analysis.

Authors:  Xuan Su; Zhaoqu Li; Caiyun He; Weichao Chen; Xiaoyan Fu; Ankui Yang
Journal:  Oncotarget       Date:  2016-03-29

4.  GADD45B Transcript Is a Prognostic Marker in Papillary Thyroid Carcinoma Patients Treated With Total Thyroidectomy and Radioiodine Therapy.

Authors:  Mateus C Barros-Filho; Julia B H de Mello; Fabio A Marchi; Clóvis A L Pinto; Igor C da Silva; Patricia K F Damasceno; Milena B P Soares; Luiz P Kowalski; Silvia R Rogatto
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-30       Impact factor: 5.555

5.  The BRAFV600E Mutation Is Not a Risk Factor for More Aggressive Tumor Behavior in Radiogenic and Sporadic Papillary Thyroid Carcinoma at a Young Age.

Authors:  Liudmyla Zurnadzhy; Tetiana Bogdanova; Tatiana I Rogounovitch; Masahiro Ito; Mykola Tronko; Shunichi Yamashita; Norisato Mitsutake; Serhii Chernyshov; Sergii Masiuk; Vladimir A Saenko
Journal:  Cancers (Basel)       Date:  2021-11-30       Impact factor: 6.639

6.  Association between the rs2910164 polymorphism in pre-Mir-146a sequence and thyroid carcinogenesis.

Authors:  Wen-Jun Wei; Yu-Long Wang; Duan-Shu Li; Yu Wang; Xiao-Feng Wang; Yong-Xue Zhu; Ya-Jun Yang; Zhuo-Ying Wang; Yan-Yun Ma; Yi Wu; Li Jin; Qing-Hai Ji; Jiu-Cun Wang
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

7.  BRAF V600E and RET/PTC Promote the Activity of Nuclear Factor-κB, Inflammatory Mediators, and Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Study of 50 Patients in Inner Mongolia.

Authors:  Dehua Zhou; Zhou Li; Xuefeng Bai
Journal:  Med Sci Monit       Date:  2018-09-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.